Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H11ClFN3O2 |
| Molecular Weight | 319.718 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=NC=NC(NC3=CC(Cl)=C(F)C=C3)=C2C=C1O
InChI
InChIKey=JLVTVCRXFMLUIF-UHFFFAOYSA-N
InChI=1S/C15H11ClFN3O2/c1-22-14-6-12-9(5-13(14)21)15(19-7-18-12)20-8-2-3-11(17)10(16)4-8/h2-7,21H,1H3,(H,18,19,20)
| Molecular Formula | C15H11ClFN3O2 |
| Molecular Weight | 319.718 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of polymorphisms in CYP2D6 and ABC transporters and side effects induced by gefitinib on the pharmacokinetics of the gefitinib metabolite, O-desmethyl gefitinib. | 2016-06 |
|
| Inhibition of SN-38 glucuronidation by gefitinib and its metabolite. | 2015-06 |
|
| Cytochrome P450-dependent metabolism of gefitinib. | 2005-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:50:18 GMT 2025
by
admin
on
Mon Mar 31 22:50:18 GMT 2025
|
| Record UNII |
V26QDI5C8D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10471217
Created by
admin on Mon Mar 31 22:50:18 GMT 2025 , Edited by admin on Mon Mar 31 22:50:18 GMT 2025
|
PRIMARY | |||
|
184475-71-6
Created by
admin on Mon Mar 31 22:50:18 GMT 2025 , Edited by admin on Mon Mar 31 22:50:18 GMT 2025
|
PRIMARY | |||
|
DTXSID40440527
Created by
admin on Mon Mar 31 22:50:18 GMT 2025 , Edited by admin on Mon Mar 31 22:50:18 GMT 2025
|
PRIMARY | |||
|
V26QDI5C8D
Created by
admin on Mon Mar 31 22:50:18 GMT 2025 , Edited by admin on Mon Mar 31 22:50:18 GMT 2025
|
PRIMARY |